PAR-21-045 - Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
NOT-OD-22-179 |
ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO
|
Jul 14, 2022 |
May 8, 2025
|
R21, R01, R61/R33, UG3/UH3, R34, U01 |
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
NOT-OD-22-107 |
ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO
|
May 12, 2022 |
May 8, 2025
|
333, R01, R34, R21, R61/R33, U01, UG3/UH3 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas |
NOT-AR-22-007 |
NIAMS
|
Sep 23, 2021 |
Jan 10, 2023
|
R01, R21, R15, R33, R13, R34, K99/R00, K24, K01, K25, K23, K08, 332 |
|